白云山子公司获药品生产许可证 生产范围有所核减

财中社
21 Apr

4月21日,白云山(600332/00874)发布公告,子公司明兴药业近日获得广东省药品监督管理局核准签发的《药品生产许可证》,并进行了生产范围、生产车间和生产线的核减。具体来说,明兴药业在“广州市黄埔区尖塔山路1号”的生产地址核减了“冻干粉针剂(含抗肿瘤药)”的生产范围及相应的生产线。此次变更旨在进一步整合生产资源和优化产能布局,预计将有助于维持公司的生产能力,满足市场需求。公告中提到,获得《...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10